MENU
GNLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Genelux (GNLX) Earnings Date & Reports

Genelux Corp is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

GNLX is expected to report earnings to rise 4.76% to -21 cents per share on April 06

Genelux GNLX Stock Earnings Reports
Q4'25
Est.
$-0.22
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.01
Q4'24
Est.
$-0.25
The last earnings report on November 05 showed earnings per share of -20 cents, beating the estimate of -21 cents. With 371.74K shares outstanding, the current market capitalization sits at 116.72M.
View a ticker or compare two or three
GNLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GNLX showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
23
Web
https://www.genelux.com